Order results by:
| Issue | Title | |
| Vol 12, No 2 (2020) | Systematic analysis of the molecular pathophysiology of tenosynovitis: promise for using chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, O. A. Limanova | ||
| "... The chondroprotectors glucosamine sulfate (GS) and chondroitin sulfate (CS) show a complex anti ..." | ||
| Vol 11, No 1 (2019) | Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov | ||
| "... and to justify the use of chondroitin sulfate (CS) and glucosamine sulfate (GS) in these patients. The molecular ..." | ||
| Vol 13, No 4 (2021) | Toll-like receptors as a part of osteoarthritis pathophysiology: anti-inflammatory, analgesic and neuroprotective effects | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. M. Lila, L. I. Alekseeva, E. A. Taskina | ||
| "... based on standardized forms of chondroitin sulfate (CS), which have symptom-modifying and structural ..." | ||
| Vol 12, No 6 (2020) | A new look at back pain treatment in light of the latest ESCEO guidelines | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. A. Prokofyeva | ||
| "... that the intramuscular administration of CPs (chondroitin sulfate (CS) in particular) can increase their bioavailability ..." | ||
| Vol 11, No 3 (2019) | On the neurological roles of chondroitin sulfate and glucosamine sulfate: a systematic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. A. Semenov, L. I. Stakhovskaya, K. V. Rudakov | ||
| "... Chondroitin sulfate (CS) and glucosamine sulfate (GS) are widely used as chondroprotectors. Data ..." | ||
| Vol 12, No 5 (2020) | Anti-inflammatory and anti-aging effects of chondroitin sulfate | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. S. Prokofyeva | ||
| "... background. Anti-inflammatory drugs include chondroitin sulfate (CS) that, in addition to directly affecting ..." | ||
| Vol 14, No 6 (2022) | On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis | Abstract similar documents |
| O. A. Gromova, I. Y. Torshin, A. M. Lila | ||
| "... of cartilage (chondroprotection), will be symptomatic. The chondroprotective effects of glucosamine sulfate (GS ..." | ||
| Vol 14, No 4 (2022) | Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views | Abstract similar documents |
| O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy | ||
| "... and Osteoarthritis (ESCEO, 2020) – on the prescription of SYSADOA, which include chondroitin sulfate (CS ..." | ||
| Vol 12, No 3 (2020) | Experience with chondroitin sulfate in the combination therapy of lower back pain | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, Yu. S. Prokofyeva | ||
| "... drugs (NSAIDs). Objective: to determine the magnitude of the effect of injectable chondroitin sulfate ..." | ||
| Vol 15, No 2 (2023) | New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council | Abstract similar documents |
| Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova | ||
| "... drugs, DMOADs): chondroitin sulfate, glucosamine sulfate, undenatured type II collagen for adjuvant ..." | ||
| Vol 15, No 4 (2023) | Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity | Abstract similar documents |
| O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... sulfate and glucosamine sulfate) as well as NK-II, will make it possible to influence the key sites ..." | ||
| Vol 4, No 2 (2012) | Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis | Abstract similar documents |
| V V Badokin | ||
| "... , particularly structural analogues of the cartilage (glucosamine and chondroitin sulfate), that have ..." | ||
| Vol 13, No 6 (2021) | Role of chondroitin sulfate in the regulation of neuroimmunoendocrine network interactions in patients with neurological symptoms in the post-covid period | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, M. Yu. Maksimova, M. N. Sharov, Yu. S. Prokofyeva | ||
| "... The review discusses the prospects for the use of chondroitin sulfate and its derivatives for new ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... on the relationship between mechanisms of chondroitin sulfate and its derivatives (chondroitin sulfate glycoprotein ..." | ||
| Vol 13, No 1 (2021) | Systematic analysis of molecular biological mechanisms for supporting connective tissue metabolism with chondroitin sulfate | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, G. I. Nechaeva, I. A. Reier, N. V. Zagorodniy | ||
| "... chondroitin sulfate (CS) and connective tissue (CT) disease. A total of 922 publications on the relationship ..." | ||
| Vol 10, No 2 (2018) | Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov | ||
| "... of the chondroprotector Sustaguard® Arthro based on the microcrystalline pharmaceutical substance glucosamine sulfate (GS ..." | ||
| Vol 13, No 2 (2021) | Motor dysfunction in elderly patients with chronic musculoskeletal system diseases (locomotive syndrome) | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. A. Gromova, I. Yu. Torshin, M. Yu. Maksimova, Yu. S. Prokofieva | ||
| "... micronutrients, which include highly purified forms of chondroitin sulfate and glucosamine sulfate, which have ..." | ||
| Vol 13, No 3 (2021) | Chondroitin sulfate in osteoarthritis treatment in patients with comorbid cardiovascular diseases: hypertension, atherosclerosis, coronary heart disease | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, I. V. Sarvilina, N. I. Shavlovskiy, Yu. D. Yukhnovskaya | ||
| "... sulfate (CS). According to the 2019–2020 International and Russian guidelines, only pharmaceutical-grade ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... : to compare the clinical course of COVID-19 in patients with PD who took or did not take amantadine sulfate ..." | ||
| Vol 14, No 2 (2022) | Post-COVID pain syndrome: a review of international observations | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy | ||
| "... of pharmaceutically standardized drugs – chondroitin sulfate (CS) and glucosamine sulfate (GS) are preferred. GS ..." | ||
| Vol 9, No 3 (2017) | Molecular effects of chondroguard in osteoarthritis and herniated discs | Abstract similar documents |
| A. M. Lila, O. A. Gromova, I. Yu. Torshin, A. G. Nazarenko, A. Yu. Gogolev | ||
| "... Chondroitin sulfates (CS) are a building material for the cartilage and have anti-inflammatory ..." | ||
| Vol 6, No 4 (2014) | Dopaminergic deficiency syndrome in the picture of severe brain injury in the presence of protracted depression of consciousness | Abstract similar documents |
| M. V. Chelyapina, E. V. Sharova, O. S. Zaitsev | ||
| "... and anterior temporal regions. The administration of amantadine sulfate was followed by an increase (even ..." | ||
| Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
| A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
| "... sulfate (PK-Merz) is being considered, which has a complex effect on neurotransmitter systems and has been ..." | ||
| Vol 15, No 6 (2023) | Admitting a patient with musculoskeletal pain following COVID-19 disease | Abstract similar documents |
| I. D. Romanov, O. A. Shavlovskaya, I. A. Bokova | ||
| Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
| M. R. Nodel | ||
| Vol 12, No 4 (2020) | Current concept of the pathophysiology of migraine and new targets for its therapy | Abstract PDF (Eng) similar documents |
| G. R. Tabeeva, Z. Katsapava | ||
| "... Мигрень является распространенным хроническим неврологическим заболеванием. Патофизиология головной ..." | ||
| Vol 13, No 1 (2021) | Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy | Abstract similar documents |
| Z. A. Zalyalova | ||
| Vol 2, No 2 (2010) | Cervicogenic headache: pathophysiology, clinical picture, approaches to therapy | Abstract similar documents |
| G. R. Tabeeva, A. V. Sergeev | ||
| Vol 15, No 1 (2023) | Chondroprotectors as modulators of neuroinflammation | Abstract similar documents |
| I. Y. Torshin, O. A. Gromova, A. G. Nazarenko | ||
| "... Modern fundamental and clinical studies show that chondroprotector molecules (chondroitin sulfate ..." | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... ), anticholinergics (biperiden), amantadines (amantadine sulfate). Before starting treatment and after completion ..." | ||
| Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
| E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
| "... adamantanes (four – amantadine sulfate, three – amantadine hydrochloride, one – memantine) in the complex ..." | ||
| Vol 4, No 1 (2012) | Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... Приведены особенности клиники и патофизиологии нарушений сна и бодрствования у пациентов с болезнью ..." | ||
| Vol 2, No 4 (2010) | Pericranial muscle dysfunction in primary headache and its correction | Abstract similar documents |
| V. V. Osipova | ||
| "... напряжения в патофизиологии ГБН. Обсуждаются подходы к лечению мышечного напряжения у пациентов с первичной ..." | ||
| Vol 6, No 2 (2014) | Epidural glucocorticoid use for vertebrogenic pain | Abstract similar documents |
| M.V. Churyukanov, O.A. Chernenko | ||
| "... неспецифического характера и радикулопатии. Обсуждаются вопросы патофизиологии радикулопатии, роли механического и ..." | ||
| Vol 16, No 4 (2024) | Malingering and functional movement disorder | Abstract similar documents |
| K. M. Evdokimov, E. Yu. Fedotova, S. N. Illarioshkin | ||
| "... патофизиологии ФДР. Одним из сложных вопросов является выделение ФДР в отдельную группу, отличную от фиктивного ..." | ||
| Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
| M. R. Nodel, G. V. Kovrov | ||
| "... , современные подходы к их диагностике. Обсуждается многофакторность патофизиологии этих нарушений. Описываются ..." | ||
| Vol 8, No 4 (2016) | HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE | Abstract similar documents |
| M. R. Nodel | ||
| "... современные подходы к диагностике гиперсомнии при БП. Обсуждается многофакторность ее патофизиологии у ..." | ||
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... В статье приведены особенности клиники и патофизиологии нарушений сна и бодрствования у пациентов с ..." | ||
| Vol 11, No 4 (2019) | Cognitive impairment and mental disorders in patients with focal muscular dystonia | Abstract similar documents |
| V. A. Tolmacheva, D. A. Grishina, D. V. Romanov | ||
| "... и соматизированные расстройства. Патофизиология недвигательных проявлений ФМД, вероятно, зависит от ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... патофизиологии прогрессирования РС, особенностях механизма действия сипонимода, эффективности и безопасности его ..." | ||
| Online-first | Когнитивные и психические нарушения у пациентов с фокальной мышечной дистонией | Abstract similar documents |
| В. A. Толмачева, Д. А. Гришина, Д. В. Романов | ||
| "... состояний. У 6 (40%) пациентов с ФМД имелись тревожные и соматизированные расстройства. Патофизиология ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... и созревании иммунных клеток; было показано, что они вовлечены и в патофизиологию РС. Кроме того, на ..." | ||
| Vol 17, No 3 (2025) | Structural and functional brain changes in body dysmorphic disorder according to neuroimaging data | Abstract similar documents |
| V. E. Medvedev | ||
| "... нейровизуализации при ДМ, могут помочь пролить свет на патофизиологию и нейробиологические основы этого состояния. В ..." | ||
| Vol 13, No 5 (2021) | Association of polymorphic variants of genes (HTR2A, MTNR1A, MTNR1B, CLOCK, DRD2) and insomnia in alcohol dependence syndrome | Abstract PDF (Eng) similar documents |
| I. S. Efremov, A. R. Asadullin, V. S. Dobrodeeva, N. A. Shnayder, E. A. Akhmetova, D. R. Tukhvatullina, E. M. Krupitsky, R. F. Nasyrova | ||
| "... патофизиологии нарушений сна у пациентов с алкогольной зависимостью и поиске патогенетической терапии бессонницы. ..." | ||
| Vol 12, No 2 (2020) | Myofascial pain syndrome in female patients with chronic nonspecific back pain: diagnosis and treatment | Abstract similar documents |
| D. O. Rozhkov, O. E. Zinovyeva, A. N. Barinov, I. M. Vikhlyantsev, G. Z. Mikhailova, N. V. Penkov, A. M. Nosovsky | ||
| "... of sodium dodecyl sulfate (SDS) gel electrophoresis indicated a decrease in the content of titin and nebulin ..." | ||
| 1 - 45 of 45 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
